Resilient Drug Supply: Newsletter Archive

CIDRAP Resilient Drug Supply Project Newsletter - Nov 30, 2023
Efforts to boost supplies of new RSV monoclonal antibody treatment for infants, President Biden's plan to strengthen US supply chains, and more

CIDRAP Resilient Drug Supply Project Newsletter - Nov 8, 2023
RSV-preventing drug in shortage, strained influenza antiviral supplies, the latest FDA warning letters, and more

CIDRAP Resilient Drug Supply Project Newsletter - Oct 2, 2023
New report on five major drug companies' efforts to boost access to generic and biosimilar drugs, the latest on ADHD and antibiotic drug shortages, and more

CIDRAP Resilient Drug Supply Project Newsletter - Aug 28, 2023
Shortcuts and coverups in drug plants often lead to quality problems and shortages, the latest news on US and global drug shortages, and more

CIDRAP Resilient Drug Supply Project Newsletter - Aug 2, 2023
Most drugs made at tornado-ravaged Pfizer plant available from other suppliers, the latest on worsening opioid shortages, and more

CIDRAP Resilient Drug Supply Project Newsletter - Jun 29, 2023
Policymakers act to mitigate US drug shortages, Brookings experts propose steps toward shoring up the supply chain, and more

CIDRAP Resilient Drug Supply Project Newsletter - Jun 15, 2023
Life-threatening cancer drug shortages, drug-quality problems overseas, and more

CIDRAP Resilient Drug Supply Project Newsletter - Jun 1, 2023
The WHO's efforts to ensure access to medical oxygen in developing countries, the latest on cancer drug shortages, and more

CIDRAP Resilient Drug Supply Project Newsletter - May 18, 2023
Some seeking weight-loss drug risk ordering it online from compounding pharmacies, US drug shortages at all-time high, and more

CIDRAP Resilient Drug Supply Project Newsletter - May 4, 2023
An update on the Pluvicto prostate-cancer drug shortage, drugs that have been in shortage in the United States for 8 years, and more

CIDRAP Resilient Drug Supply Project Newsletter - Apr 20, 2023
Bipartisan support grows for laws aimed at reducing US drug shortages, shortages of medical liquid oxygen in low- and middle-income countries, and more

CIDRAP Resilient Drug Supply Project Newsletter - Apr 6, 2023
Countries look to rewrite laws and use other tactics to combat drug shortages, continuing cancer-drug shortages, and more

CIDRAP Resilient Drug Supply Project Newsletter - Mar 16, 2023
The possible consequences of the shortage of four cancer drugs, how the opioid settlement hinders patient access to a wide variety of drugs, and more

CIDRAP Resilient Drug Supply Project Newsletter - Mar 3, 2023
How the cost of China-made active pharmaceutical ingredients doubled during the pandemic, the latest on the albuterol shortage, and more

CIDRAP Resilient Drug Supply Project Newsletter - Feb 16, 2023
Longtime drug shortage leads to substandard care for thousands of US bladder cancer patients, possible effects of the downed spy balloon on US-China medical supply chains, and more

CIDRAP Resilient Drug Supply Project Newsletter - Feb 2, 2023
Experts give recommendations on strengthening the US drug supply chain, drug-shortage updates, FDA citations, and more

CIDRAP Resilient Drug Supply Project Newsletter - Jan 19, 2023
Why Chinese citizens are turning to the black market amid COVID-19 drug shortages, some retail pharmacies drop purchasing restrictions for kids' over-the-counter medicines, and more

CIDRAP Resilient Drug Supply Project Newsletter - Jan 5, 2023
The reasons behind the rapidly fluctuating demand for blood thinners during the pandemic, the latest on the lidocaine and Wegovy shortages, and more

CIDRAP Resilient Drug Supply Project Newsletter - Dec 22, 2022
HHS expands access to scarce flu antiviral drug Tamiflu, updates on the amoxicillin, diabetes drug, and Adderall shortages, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Dec 8, 2022
Low provider adherence to restrictions on scarce antibiotics, the latest on shortages of amoxicillin, kids' fever and pain meds, and Adderall, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Nov 23, 2022
The latest Access to Medicine Index shows that pharma firms must boost access for low- and middle-income countries and R&D for pandemic threats, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Nov 10, 2022
How Europe's energy crisis could portend US drug shortages, why Canadians are crossing the border for a common over-the-counter medication, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Oct 27, 2022
Doctors, pharmacist coping with amoxicillin shortage, the Adderall shortage, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Oct 13, 2022
Low access to insulin in poor countries hinders diabetes care, the latest on the Adderall shortage, recent FDA Form 483s, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Sep 29, 2022
Hospital pharmacists to help mitigate cancer drug shortages, US-China supply chain decoupling, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Sep 15, 2022
Canada and UK broaden mutual recognition of foreign inspections, Biden's executive order on advancing biomanufacturing, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Sep 1, 2022
The latest report from the US Office of Pharmaceutical Quality, the Adderall shortage, monkeypox vaccine dosing, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Aug 18, 2022
Countries face critical drug shortages, ASHP pharmacist survey results, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Aug 4, 2022
Emergency medical services facing critical dextrose shortage, scarce monkeypox vaccines, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Jul 22, 2022
Monkeypox epidemic control hinging on availability of scarce vaccines, US dependence on foreign drug suppliers, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Jul 7, 2022
New processing platforms for pharmaceutical production, Eli Lilly to supply 150,000 more doses of bebtelovimab, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Jun 9, 2022
US wasted COVID-19 doses, the supply chain disruptions that are stressing hospitals, and more.

CIDRAP Resilient Drug Supply Project Newsletter - May 27, 2022
New ASPR report bares frayed, fractured US drug supply chains, Shanghai pharma manufacturing halves in April, and more.

CIDRAP Resilient Drug Supply Project Newsletter - May 12, 2022
Proposed bill designed to urge medicines manufacturing in US, Vizient and RISCS join forces over pharma supply chain project, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Apr 28, 2022
The impact of India and China's latest COVID surges on global drug supply chains, RDSP's medicine map, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Apr 14, 2022
FDA to conduct unannounced inspections in India, lawmakers introduce flurry of bills on drug pricing and supply issues, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Mar 31, 2022
Supply map created to predict drug shortages, effects of the war in Ukraine on the pharma supply chain, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Mar 18, 2022
New NASEM report urges medical supply chain transparency, agility, the war in Ukraine threatens medical supply chains, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Mar 3, 2022
Concerns about Evusheld access and supply, generic firms' likelihood to withdraw drugs if US FDA pursues PANDA policy, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Feb 18, 2022
Physician survey reveals cracks in the US drug supply chain, supplies of molnupiravir and Paxlovid waiting for patients, and more

CIDRAP Resilient Drug Supply Project Newsletter - Feb 3, 2022
India to require database-linked QR codes for APIs, EU Parliament strengthens drug regulators' ability  to tackle shortages, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Jan 20, 2022
Firm tackles US drug supply shortages with Wisconsin plant, COVID drug shortages and allocation inequities, and more.

CIDRAP Resilient Drug Supply Project Newsletter - Jan 6, 2022
Drug supply chain pain ahead of Winter Olympics shutdowns in China, COVID-19 pills and vaccines, and more.